USPTO grants patent to Tiziana for fully human monoclonal antibody, TZLS-501
The grant of this additional patent on TZLS-501 is of significance for the potential treatment of COVID-19 and other pulmonary…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Tiziana Life Sciences
Tiziana Life Sciences to expedite development of TZLS-501 for COVID-19
TZLS-501 is a novel fully human anti-interleukin-6 receptor (anti-IL6R) monoclonal antibody (mAb) for treatment of patients…